Evinacumab
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 211 publications
New and Emerging Therapeutic Targets for ApoB-Containing Particles Lowering.
Journal: Circulation research
Published: June 04, 2026
Translating Lipoprotein Genetics Into New Therapies.
Journal: Circulation research
Published: June 04, 2026
Drugs for hypercholesterolemia.
Journal: The Medical letter on drugs and therapeutics
Published: June 01, 2026
Current and Future Perspectives of LDL-C Lowering Therapies 2026.
Journal: Journal of atherosclerosis and thrombosis
Published: May 27, 2026
Promise of ANGPTL3 as a therapeutic target for controlling cholesterol levels.
Journal: Expert opinion on therapeutic targets
Published: May 07, 2026
Management of autosomal recessive hypercholesterolemia in a patient with an LDLRAP1 mutation.
Journal: Journal of clinical lipidology
Published: April 02, 2026
Homozygous familial hypercholesterolemia (HoFH) in Canada.
Journal: Atherosclerosis
Published: March 20, 2026
Current and Emerging Pharmacological Therapies for Hypertriglyceridemia.
Journal: International journal of molecular sciences
Published: February 28, 2026
Advanced therapy in familial hypercholesterolemia.
Journal: Canadian family physician Medecin de famille canadien
Published: February 12, 2026
Targeting triglycerides for cardiovascular risk reduction.
Journal: Internal and emergency medicine
Published: February 09, 2026
Novel Approaches to Lipid Management: Beyond Statins and PCSK9 Inhibitors.
Journal: Journal of clinical medicine research
Published: January 30, 2026
Update on familial hypercholesterolemia: An expert clinical consensus from the National Lipid Association.
Journal: Journal of clinical lipidology
Published: January 07, 2026
Last Updated: 06/30/2026